Synsorb-Pk: Began a Phase I trial

Alberta Research Council Product: Synsorb-Pk, porous particles with attached sugars that bind to toxins Indication: Hemolytic uremic syndrome Status: Began a Phase I trial Note: ARC plans to commerci...